您的位置: 首页 > 农业专利 > 详情页

THERAPIE D'ASSOCIATION UTILISANT DES INHIBITEURS DE TRANSCRIPTION ET DES INHIBITEURS DE KINASES
专利权人:
INC.;DANA-FARBER CANCER INSTITUTE
发明人:
HAMMERMAN, PETER,WONG, KWOK-KIN,GRAY, NATHANAEL S.
申请号:
CA2986441
公开号:
CA2986441A1
申请日:
2016.06.10
申请国别(地区):
CA
年份:
2016
代理人:
摘要:
The present disclosure provides combination therapy of a transcription inhibitor and a kinase inhibitor. The combination of the transcription inhibitor and the kinase inhibitor may be useful in treating and/or preventing in a subject a proliferative disease, such as proliferative a disease that is resistant to the transcription inhibitor alone or the kinase inhibitor alone. In certain embodiments, the proliferative disease is a cancer. The combination of the transcription inhibitor and the kinase inhibitor is expected to be synergistic.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充